MARC details
000 -LEADER |
fixed length control field |
03111cam a22003378i 4500 |
001 - CONTROL NUMBER |
control field |
on1376195144 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230830152935.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
230310s2023 nyu e b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2023003973 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
Modifying agency |
OCLCF |
-- |
ORX |
-- |
TOH |
-- |
YDX |
-- |
LJW |
-- |
GO6 |
-- |
RNL |
-- |
BDX |
-- |
IL2 |
-- |
VP@ |
-- |
NFG |
019 ## - |
-- |
1355638794 |
-- |
1378016873 |
-- |
1388679583 |
-- |
1391693494 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781538724613 |
Qualifying information |
(hardcover) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1538724618 |
Qualifying information |
(hardcover) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1376195144 |
Canceled/invalid control number |
(OCoLC)1355638794 |
-- |
(OCoLC)1378016873 |
-- |
(OCoLC)1388679583 |
-- |
(OCoLC)1391693494 |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
Classification number |
616.8527 |
Item number |
G618 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
NFGA |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gold, Philip W., |
Dates associated with a name |
1944- |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Breaking through depression : |
Remainder of title |
a guide to the next generation of promising research and revolutionary new treatments / |
Statement of responsibility, etc |
Philip William Gold, MD. |
250 ## - EDITION STATEMENT |
Edition statement |
First edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
Place of production, publication, distribution, manufacture |
New York, NY : |
Name of producer, publisher, distributor, manufacturer |
Twelve, |
Date of production, publication, distribution, manufacture |
2023. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiii, 257 pages ; |
Dimensions |
24 cm. |
336 ## - CONTENT TYPE |
Content Type Term |
text |
Content Type Code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media Type Term |
unmediated |
Media Type Code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier Type Term |
volume |
Carrier Type Code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references (pages 219-244) and index. |
520 ## - SUMMARY, ETC. |
Summary, etc |
"Breaking through depression explores how the anatomy of the brain and the biochemistry of nerve impulses play a major role in how we view ourselves and the world. Drawing from his long-term research, Dr. Philip Gold makes the case for depression arising at the intersection of genetic vulnerability with stressful, disturbing life experiences that get encoded in our emotional memory. Breaking through depression will delve into the interplay between our anatomy and our lived experiences as the key to understanding why there are such individual differences in how we make connections with others, deal with adversity, or recover from trauma. More importantly, Dr. Gold reveals the latest breakthroughs that can heal people struggling with depression, including: -The FDA has fast-tracked Psilocybin and Ketamine as an anti-depressant treatments, which cause immediate improvement in depressive symptoms. -Low-energy lasers have been developed that can stimulate these areas directly and painlessly to relieve symptoms in treatment-resistant patients suffering from major depression. -Scientists are developing genetically 'thumbprinted' antidepressants that can be individually tailored to match a person's DNA increasing their effectiveness. -Inflammation in the body and the brain is a prominent component of depressive illness, to the point that anti-inflammatory agents are useful in the treatment of depression. -Incredible progress with gene therapy including a treatment overcoming the BDNF gene mutation that interferes with resiliency, promotes vulnerability to depression, and inhibits the capacity of antidepressants to work effectively. These are just a few of the fascinating new developments explored in Breaking through depression and the many reasons for hope that Dr. Gold shares in this groundbreaking book"-- |
Assigning source |
Provided by publisher. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Depression, Mental |
Form subdivision |
Popular works. |
9 (RLIN) |
119996 |
994 ## - |
-- |
C0 |
-- |
NFG |